Omaha, NE – Streck’s A1c-Cellular® Linearity is now assayed for the Ortho-Clinical Diagnostics VITROS® 4600.

A1c-Cellular Linearity is the only commercially available HbA1c linearity/calibration verification material with intact red blood cells. A1c-Cellular Linearity assesses the accuracy and linear reportable range of the HbA1c parameter. It tests the entire HbA1c procedure, including the lysing of the red blood cell – a step omitted with other linearity materials.

A1c-Cellular Linearity is also assayed for: Abbott ARCHITECT® c Systems, Beckman Coulter® UniCel® DxC 600/800, Bio-Rad® D-10™/Variant II™/Variant II™ Turbo, Siemens Dimension Series, VITROS® 5,1 FS/5600, Roche cobas INTEGRA®/6000 /c 311, Tosoh G7/G8 and Trinity Biotech Premier Hb9210™.

A1c-Cellular Linearity is packaged in a 5-level set with plastic cap-pierceable vials which allow autosampling for HbA1c analyzers with such capabilities. It has 105-day closed-vial stability and 7-day open-vial stability.

Streck also offers A1c-Cellular®, the first HbA1c control available with intact red blood cells. The product is a ready-to-use liquid control appropriate for immunoassay and ionic exchange HPLC methodologies, with 180-day closed-vial stability and 30-day open-vial stability.

About Streck, Inc.
Streck is an industry leader in the development and manufacturing of products for clinical and research laboratories. The company’s pursuit of innovative solutions has produced an extensive list of patented products. Streck’s core technology is cell stabilization; product lines support the fields of hematology, immunology and molecular diagnostics. For more information, visit

What we offer

Upcoming Events >